Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Robinhood Markets, Inc. (HOOD) Price & Performance

Cassava Sciences IncTrade
Robinhood Markets, Inc.Trade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Robinhood Markets, Inc. — how do they compare? Cassava Sciences Inc trades at $0.94 (market cap $47.75M), while Robinhood Markets, Inc. trades at $95.12 (market cap $84.86B). The key difference: Robinhood Markets, Inc. is far larger — about 1777.2× Cassava Sciences Inc's market cap, and Robinhood Markets, Inc. is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

FLNAHOOD
Market Cap
$47.75M$84.86B
Sector
HealthTechnology
52-Week High
$4.64$152.46
52-Week Low
$0.87$65.16
Enterprise Value
-$34.93M$91.40B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.9528, down 4.46% today, with a bearish technical outlook but strong analyst support (66.7% buy ratings). The company continues to post net losses and negative cash flows, though recent EPS beats show some operational improvement. Recent news highlights Q2 2026 results and business updates on Tuberous Sclerosis Complex therapies.

The outlook remains speculative due to persistent unprofitability and cash burn, but analyst optimism and a low P/B ratio of 0.75 may attract value investors. Key risks include execution challenges in drug development and reliance on financing amid negative earnings.

Robinhood Markets, Inc.

Robinhood Markets (HOOD) trades at $94.40, down 0.13% on the day, with a bearish technical signal despite strong fundamentals. The company reported robust Q2 2026 results with revenue growth of 32% and earnings beating expectations, driven by diversification beyond crypto into event contracts and international expansion. Valuation metrics remain elevated with P/E of 41.76 and P/S of 17.6, reflecting premium pricing for growth prospects.

The outlook remains positive with analyst consensus pointing to significant upside (target $123.46), though near-term technical weakness and competitive pressures in the UK crypto expansion present risks. Revenue diversification and strong cash flow generation support long-term growth, but investors should monitor execution on international expansion and margin sustainability amid high valuations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA

About Robinhood Markets, Inc.

Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.

Read more on HOOD